Received an Allogeneic hematologic stem cell transplantation at least 3 months prior.

Subjects with post Allogeneic hematologic stem cell transplantation onset or worsening of dry eye symptoms for at least 1 month prior.

Use of over-the-counter and/or prescription eye drops for dry eye symptoms within 1 month.

Corneal fluorescein staining score of ≥ 2 in 1 region and ≥ 1 in at least 1 other region.

Total lissamine green conjunctival staining score (according to a modified National Eye Institute grading system) of ≥ 2.

Safety and Efficacy Study of R932348 Ophthalmic Solution in Chronic Ocular Graft Versus Host Disease Patients(DROPS-2)